Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy

Loosen, Sven H; Schneider, Anne Theres; Koppe, Christiane; Vucur, Mihael; Tacke, Frank; Beier, Fabian; Kather, Jakob N.; Gorgulho, Joao; Roderburg, Christoph; Schulze-Hagen, Maximilian; Keitel, Verena; Mertens, Alexander; Brümmendorf, Tim Henrik; Jördens, Markus S.; Luedde, Tom

doi:2234-943X

%0 Journal Article
%A Loosen, Sven H
%A Gorgulho, Joao
%A Jördens, Markus S.
%A Schulze-Hagen, Maximilian
%A Beier, Fabian
%A Vucur, Mihael
%A Schneider, Anne Theres
%A Koppe, Christiane
%A Mertens, Alexander
%A Kather, Jakob N.
%A Tacke, Frank
%A Keitel, Verena
%A Brümmendorf, Tim Henrik
%A Roderburg, Christoph
%A Luedde, Tom
%T Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
%J Frontiers in oncology
%V 11
%@ 2234-943X
%C Lausanne
%I Frontiers Media
%M RWTH-CONV-248259
%P 646883
%D 2021
%F PUB:(DE-HGF)16 ; PUB:(DE-HGF)7
%9 Journal ArticleContribution to a book
%U <Go to ISI:>//WOS:000640331500001
%$ pmid:33869041
%R 10.3389/fonc.2021.646883
%U https://publications.rwth-aachen.de/record/851171

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines